Garland Capital Management Inc Organon & Co. Transaction History

Garland Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$16.59 - $23.77 $2,986 - $4,278	180 Added 0.11%	162,797 $2.83 Million
Q2 2023 Jul 20, 2023	BUY	$19.27 - $24.63 $65,903 - $84,234	3,420 Added 2.15%	162,617 $3.38 Million
Q1 2023 Apr 25, 2023	SELL	$21.42 - $32.08 $122,094 - $182,856	-5,700 Reduced 3.46%	159,197 $3.74 Million
Q4 2022 Jan 19, 2023	BUY	$23.31 - $28.61 $158,158 - $194,118	6,785 Added 4.29%	164,897 $0
Q3 2022 Oct 20, 2022	BUY	$23.4 - $34.25 $69,615 - $101,893	2,975 Added 1.92%	158,112 $3.7 Million
Q2 2022 Jul 20, 2022	BUY	$31.66 - $38.9 $96,721 - $118,839	3,055 Added 2.01%	155,137 $5.24 Million
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $60 - $78	-2 Reduced -0.0%	152,082 $5.31 Million
Q4 2021 Feb 03, 2022	SELL	$28.67 - $37.13 $469,041 - $607,446	-16,360 Reduced 9.71%	152,084 $4.63 Million
Q3 2021 Oct 27, 2021	BUY	$28.63 - $35.64 $21,472 - $26,730	750 Added 0.45%	168,444 $5.52 Million
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $4.77 Million - $6.37 Million	167,694 New	167,694 $5.07 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Garland Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Garland Capital Management Inc with notifications on news.